soul trial oral semaglutide cardiovascular outcomes trial results soul Oral Semaglutide's Impact on Cardiovascular Events in Type 2 Diabetes Patients with Cardiovascular and Kidney Disease: SOUL Trial Results soul trial oral semaglutide cardiovascular

The FDA approved Wegovy (semaglutide), which was previously available only as an injectable GLP-1, in pill formfor weight loss

Most evidence is preclinical, so patients should avoid treating these research themes as guaranteed clinical outcomes

The TRIUMPH-4 Retatrutide Phase 3 Data (December 2025) On December 11, 2025, Eli Lilly announced positive topline results from TRIUMPH-4

Orforglipron: Phase 3 Data Shows Ozempic-Like Results, In Pill Form Dave Knapp Apr 17, 2025 2 min read Updated: Apr 18, 2025 Eli Lillys oral GLP-1 candidate orforglipron met all primary and secondary endpoints in a Phase 3 study of adults with type 2 diabetes, the company announced Thursday

M2 macrophages are anti-inflammatory healers

Nutritional yeast is a commonly B12-enriched food source and one of my favorites